Effect of conjugated linoleic acid on body composition in mice
Y Park, KJ Albright, W Liu, JM Storkson, ME Cook… - Lipids, 1997 - Wiley Online Library
The effects of conjugated linoleic acid (CLA) on body composition were investigated. ICR
mice were fed a control diet containing 5.5% corn oil or a CLA‐supplemented diet (5.0% corn …
mice were fed a control diet containing 5.5% corn oil or a CLA‐supplemented diet (5.0% corn …
Evidence that the trans‐10,cis‐12 isomer of conjugated linoleic acid induces body composition changes in mice
Y Park, JM Storkson, KJ Albright, W Liu, MW Pariza - Lipids, 1999 - Wiley Online Library
We investigated the effects of conjugated linoleic acid (CLA) preparations, which were
enriched for the cis‐9,trans‐11 CLA isomer or the trans‐10,cis‐12 CLA isomer, on body …
enriched for the cis‐9,trans‐11 CLA isomer or the trans‐10,cis‐12 CLA isomer, on body …
Conjugated linoleic acid (CLA) content of milk from cows offered diets rich in linoleic and linolenic acid
…, LD Satter, MW Pariza, MP Galli, K Albright… - Journal of Dairy …, 2000 - Elsevier
Two experiments were conducted to determine the conjugated linoleic acid (CLA) content of
milk from cows offered diets rich in linoleic and linolenic acid. In experiment 1, 36 cows …
milk from cows offered diets rich in linoleic and linolenic acid. In experiment 1, 36 cows …
Conjugated linoleic acid is a growth factor for rats as shown by enhanced weight gain and improved feed efficiency
SF Chin, JM Storkson, KJ Albright, ME Cook… - The Journal of …, 1994 - Elsevier
We studied the effect of conjugated linoleic acid (CLA) on rat development and growth.
Primigravid female Fischer rats were fed control or CLA-supplemented (0.25% or 0.5% CLA) …
Primigravid female Fischer rats were fed control or CLA-supplemented (0.25% or 0.5% CLA) …
Changes in body composition in mice during feeding and withdrawal of conjugated linoleic acid
Y Park, KJ Albright, JM Storkson, W Liu, ME Cook… - Lipids, 1999 - Wiley Online Library
Two experiments were conducted. In Experiment 1, 8‐wk‐old mice were fed control diet or
diet supplemented with 0.5% conjugated linoleic acid (CLA) to study the effect of CLA on …
diet supplemented with 0.5% conjugated linoleic acid (CLA) to study the effect of CLA on …
Geographic access to acute stroke care in the United States
Background and Purpose— Only 3% to 5% of patients with acute ischemic stroke receive
intravenous recombinant tissue-type plasminogen activator (r-tPA) and <1% receive …
intravenous recombinant tissue-type plasminogen activator (r-tPA) and <1% receive …
Zero on the NIHSS does not equal the absence of stroke
S Martin-Schild, KC Albright, J Tanksley… - Annals of emergency …, 2011 - Elsevier
STUDY OBJECTIVE: The National Institutes of Health Stroke Scale (NIHSS) measures deficits
caused by a stroke, but not all stroke signs are captured on the NIHSS. We determine the …
caused by a stroke, but not all stroke signs are captured on the NIHSS. We determine the …
Conjugated linoleic acid (9, 11-and 10, 12-octadecadienoic acid) is produced in conventional but not germ-free rats fed linoleic acid
SF Chin, JM Storkson, W Liu, KJ Albright… - The Journal of nutrition, 1994 - Elsevier
Conjugated linoleic acid (CLA) is an anticarcinogen in several model animal systems.
Conjugated linoleic acid occurs naturally in food and is present at higher concentrations in …
Conjugated linoleic acid occurs naturally in food and is present at higher concentrations in …
Velocity criteria for intracranial stenosis revisited: an international multicenter study of transcranial Doppler and digital subtraction angiography
…, E Stamboulis, M Saqqur, MR Harrigan, KC Albright… - Stroke, 2011 - Am Heart Assoc
Background and Purpose— Intracranial atherosclerotic disease is associated with a high risk
of stroke recurrence. We aimed to determine accuracy of transcranial Doppler screening at …
of stroke recurrence. We aimed to determine accuracy of transcranial Doppler screening at …
Results of the ICTuS 2 trial (intravascular cooling in the treatment of stroke 2)
…, R Brautigam, A Alexandrov, A Sisson, K Albright… - Stroke, 2016 - Am Heart Assoc
Background and Purpose— Therapeutic hypothermia is a potent neuroprotectant approved
for cerebral protection after neonatal hypoxia-ischemia and cardiac arrest. Therapeutic …
for cerebral protection after neonatal hypoxia-ischemia and cardiac arrest. Therapeutic …